ReviewThe Lancet. Global health2022
Strengthening global health security by improving disease surveillance in remote rural areas of low-income and middle-income countries.
Review in The Lancet. Global health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
77 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Prevalence and Antimicrobial Resistance Profile of Salmonella Isolated from Human, Animal and Environment Samples in South Asia: A 10-Year Meta-analysis.Journal of epidemiology and global health · 2023Pooled it
- Community-based surveillance of infectious diseases: a systematic review of drivers of success.BMJ global health · 2022Pooled it
- Climate change, forced pastoralist migration, and zoonotic spillover in Somalia: a neglected one health threat to regional health security.One health (Amsterdam, Netherlands) · 2026Article
- Review
- Cross-Sectional Analysis of Serologic Response to Arthropod-Borne and Hemorrhagic Fever Viruses in Ghanaian Livestock Herders.The American journal of tropical medicine and hygiene · 2026Article
- Hantavirus Emergence in a Changing World: Virology, Pathogenesis, Surveillance, and One Health Preparedness.Microorganisms · 2026Review
- Modernizing public health surveillance for global health security leveraging AI.Lancet regional health. Americas · 2026Review
- Global patterns of pertussis incidence and vaccination strategies: implications of divergent surveillance data.NPJ vaccines · 2026Article
- Global, regional, and national disease burden of arthropod-borne diseases: Projections to 2030 based on the global burden of disease study 2021.PLoS neglected tropical diseases · 2026Article
- Black Carbon-Attributable Mortality and Its Disparity Across the Population Subgroups in India.GeoHealth · 2026Article
- Meningitis Mortality in U.S. Adults Aged ≥25 Years: Demographic and Geographic Insights from the CDC WONDER Database (1999-2024).Pathogens (Basel, Switzerland) · 2026Article
- Cross-national variations and demographic disparities in health surveillance system performance: a comparative analysis of OECD member countries.Health research policy and systems · 2026Article
- Detecting Influenza A(H5N1) Viruses through Severe Acute Respiratory Infection Surveillance, Cambodia.Emerging infectious diseases · 2026Article
- Pastoralists' utilization and preferences for stakeholders and methods in livestock disease reporting and response in Northern Kenya: a participatory study.BMC veterinary research · 2026Article
- Predictors of Severe Herpes Zoster: Contributions of Immunosenescence, Metabolic Risk, and Lifestyle Behaviors.Diseases (Basel, Switzerland) · 2026Article
- Evaluating the Integrated Disease Surveillance and Response system in Sidama Region, Ethiopia: A systems evaluation.PloS one · 2026Article
- Issues and principles for legitimate and meaningful One Health monitoring.International journal of public health · 2026Article
- Acceptability, feasibility and perceived benefits of integrating mental health and psychosocial support (MHPSS) into disease outbreak response in Western Uganda: a qualitative process evaluation study.BMJ public health · 2026Article
- Assessing the implementation of the disease surveillance and response strategy in Togo.PLOS global public health · 2026Article
- Integrated Surveillance for Human and Animal Brucellosis in Kenya: A Predictive Analysis.Tropical medicine and infectious disease · 2025Article
17 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
The COVID-19 pandemic has underscored the need to strengthen national surveillance systems to protect a globally connected world. In low-income and middle-income countries, zoonotic disease surveillance has advanced considerably in the past two decades. However, surveillance efforts often prioritise urban and adjacent rural communities. Communities in remote rural areas have had far less support despite having routine exposure to zoonotic diseases due to frequent contact with domestic and wild animals, and restricted access to health care. Limited disease surveillance in remote rural areas is a crucial gap in global health security. Although this point has been made in the past, practical solutions on how to implement surveillance efficiently in these resource-limited and logistically challenging settings have yet to be discussed. We highlight why investing in disease surveillance in remote rural areas of low-income and middle-income countries will benefit the global community and review current approaches. Using semi-arid regions in Kenya as a case study, we provide a practical approach by which surveillance in remote rural areas can be strengthened and integrated into existing systems. This Viewpoint represents a transition from simply highlighting the need for a more holistic approach to disease surveillance to a solid plan for how this outcome might be achieved.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.